Cmpx stock forecast.

Stock analysis for Compass Therapeutics Inc (CMPX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Compass Therapeutics Inc. (CMPX) stock is trading at $3.76 as of 3:42 PM on Friday, Jan 20, a gain of $0.01, or 0.27% from the previous closing price of $3.75. Volume today is above average. So far 918,164 shares have traded compared to average volume of 271,877 shares. The stock has traded between $3.20 and $3.88 so far today.Compound Price Live Data. The live Compound price today is $51.45 USD with a 24-hour trading volume of $77,211,369 USD. We update our COMP to USD price in real-time. Compound is up 1.11% in the last 24 hours. The current CoinMarketCap ranking is #107, with a live market cap of $412,787,173 USD. It has a circulating supply of 8,023,528 …1.57%. $249.05M. CIX | Complete CompX International Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

CompX International, Inc. engages in the manufacturer of security products used in the recreational transportation, postal, office and institutional furniture, cabinetry, tool stoFind the latest ProShares UltraPro Short QQQ (SQQQ) stock quote, history, news and other vital information to help you with your stock trading and investing.... Cmpx 2022, House of the rising sun shrewsbury, Predator alien face, Eye ... share price, Byo wedding venues philadelphia, Veterinary care near me, Tony ...

Tutorial video for Capsim business simulation. In this video, I take you on a step-by-step demonstration on how you can do Forecasting, Marketing, and Produc...According to the issued ratings of 1 analysts in the last year, the consensus rating for Kamada stock is Buy based on the current 1 buy rating for KMDA. The average twelve-month price prediction for Kamada is $11.00 with a high price target of $11.00 and a low price target of $11.00. Learn more on KMDA's analyst rating history.

The average Compass Therapeutics stock price prediction forecasts a potential upside of 528.93% from the current CMPX share price of $1.59. What is CMPX's forecast return on assets (ROA) for 2023-2026? Accurate stock price prediction has an important role in stock investment. Because stock price data are characterized by high frequency, nonlinearity, and long memory, predicting stock prices precisely is challenging. Various forecasting methods have been proposed, from classical time series methods to machine-learning-based …Compass Therapeutics, Inc. (CMPX) latest earnings report: revenue, EPS, surprise, history, news and analysis.FORECASTS Analyst Sentiment Leaderboard

Analyst Future Growth Forecasts. Earnings vs Savings Rate: CMPX is forecast to remain unprofitable over the next 3 years. Earnings vs Market: CMPX is …

Compass Therapeutics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time CMPX stock price.

Get the latest Cerner Corporation (CERN) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.The Bridgebio Pharma Inc. stock price fell by -1.28% on the last day (Wednesday, 29th Nov 2023) from $28.84 to $28.47. During the last trading day the stock fluctuated 4.69% from a day low at $28.37 to a day high of $29.70. The price has been going up and down for this period, and there has been a -3.43% loss for the last 2 weeks.Weather forecasts are essential tools for planning our daily activities, especially when it comes to the next 10 days. Understanding a weather 10 day forecast can help us make informed decisions about outdoor events, travel plans, or even w...Compass Therapeutics Inc. (CMPX) stock is trading at $3.76 as of 3:42 PM on Friday, Jan 20, a gain of $0.01, or 0.27% from the previous closing price of $3.75. Volume today is above average. So far 918,164 shares have traded compared to average volume of 271,877 shares. The stock has traded between $3.20 and $3.88 so far today.WVE. Wave Life Sciences Ltd. 5.31. -0.09. -1.67%. In this article, we will take a look at the 11 best biotech penny stocks to buy now. To see more such companies, go directly to 5 Best Biotech ...Aeterna Zentaris (TSE:AEZS) Forecast: Is this specialty biopharmaceutical company a good stock to buy? Find out the latest analysis, ratings, and price targets from TipRanks, the leading platform for financial insights.US Stock MarketDetailed Quotes. PEPG PepGen. Close 11/13 16:00 ET. 4.340. +0.480 +12.44%. High 4.762 ... Inc. (PEPG), 4D Molecular Therapeutics (FDMT) and ...

March 7, 2024. EPS forecast (this quarter) $0.30. Annual revenue (last year) $378.5M. Annual profit (last year) $18.7M. Net profit margin.Greenlane Holdings, Inc. (NASDAQ:GNLN) released its earnings results on Monday, November, 15th. The company reported ($46.00) earnings per share for the quarter, missing the consensus estimate of ($14.00) by $32.00. The company had revenue of $41.31 million for the quarter, compared to analyst estimates of $40.31 million.PSTX Stock 12 Months Forecast. $12.25. (369.35% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Poseida Therapeutics in the last 3 months. The average price target is $12.25 with a high forecast of $15.00 and a low forecast of $8.00. The average price target represents a 369.35% change from the last price of $2.61.The stock has increased 17.9% in price over the past month and closed Friday’s trading session at $3.03. Each of the four Wall Street analysts that rated ELEV rated it Buy. The 12-month median price target of $11.50 indicates a 279.5% potential upside. The price targets range from a low of $11.00 to a high of $12.00.Most recent stock forecast was given on BGNE, BeiGene, Ltd at 26-Jun-2023 ... CMPX GLUE TNGX TPTX Turning Point Therapeutics NRIX Nurix Therapeutics COGT ...18 brokerages have issued 1-year price objectives for ChargePoint's shares. Their CHPT share price targets range from $2.00 to $17.00. On average, they expect the company's share price to reach $9.13 in the next year. This suggests a possible upside of 380.1% from the stock's current price.

Back to CMPX Overview. *The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. It is possible that this date will be updated in the future, once ...CompX International, Inc. engages in the manufacturer of security products used in the recreational transportation, postal, office and institutional furniture, cabinetry, tool sto

CMPX stock forecast Our latest prediction for Compass Therapeutics Inc's stock price was made on the March 15, 2023 when the stock price was at 3.56$. In the short term (2weeks), CMPX's stock price should underperform the market by -2.94%. During that period the price should oscillate between -8.72% and +5.46%.Find the latest Compass Therapeutics, Inc. CMPX analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range investment ratingDVN Stock Forecast: DVN Increased by 110.59% with an Accuracy of 100%; MOS Stock Forecast: MOS Increased by 51.34% with an Accuracy of 100%; Energy Stocks: AI Beats the S&P500 by 50.02% with an Accuracy of 73%; COP Stock Forecast: COP Increased by 69.41% with an Accuracy of 100%; Commodity Futures: AI Beats S&P500 by 61.14%According to the issued ratings of 6 analysts in the last year, the consensus rating for Mesoblast stock is Hold based on the current 1 sell rating, 3 hold ratings and 2 buy ratings for MESO. The average twelve-month price prediction for Mesoblast is $7.13 with a high price target of $17.00 and a low price target of $1.50.Find the latest Compass Therapeutics, Inc. (CMPX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.The consensus price target of analysts on Wall Street is $9.17, which implies an increase of 78.95% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $8.00 and $11.00 respectively. As a result, CMPX is trading at a discount of -469.95% off the target high and -314.51% off the low.The Compass Therapeutics, Inc. stock price gained 6.00% on the last trading day (Friday, 17th Nov 2023), rising from $1.50 to $1.59. During the last trading day the stock fluctuated 15.61% from a day low at $1.51 to a day high of $1.74. The price has fallen in 6 of the last 10 days and is down by -14.52% for this period.

Find the latest Capital Power Corporation (CPXWF) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ...

Abstract. Biogenic secondary organic aerosols (SOAs) contribute to a large fraction of fine aerosols globally, impacting air quality and climate. The formation of biogenic SOA depends on not only emissions of biogenic volatile organic compounds (BVOCs) but also anthropogenic pollutants including primary organic aerosol, sulfur dioxide (SO2), …

View NASDAQ COMPOSITE COMPX investment & stock information. Get the latest NASDAQ COMPOSITE COMPX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.What this means: InvestorsObserver gives Compass Therapeutics Inc. (CMPX) an overall rank of 34, which is below average. Compass Therapeutics Inc. is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 34 means that 66% of stocks appear more favorable to our system. Find the latest Compass Therapeutics, Inc. CMPX analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.CMPX stock forecast Our latest prediction for Compass Therapeutics Inc's stock price was made on the March 15, 2023 when the stock price was at 3.56$. In the short term (2weeks), CMPX's stock price should underperform the market by -2.94%. During that period the price should oscillate between -8.72% and +5.46%. CompX International, Inc. engages in the manufacturer of security products used in the recreational transportation, postal, office and institutional furniture, cabinetry, tool stoCompass Therapeutics, Inc. company earnings calendar and analyst expectations - Upcoming and past events | Nasdaq: CMPX | Nasdaq 499661.RZn13_X8zmir-ZmDNDt6CBVpoKyMtbZ8jz_TNs1a5fg.Gu2S5sO-llGbyt-1YUocQSMry9i_gNNR2FnlQIYuibMJrZ6Ip5WHGsaw1AThe underwriters may also purchase up to an additional shares of our common stock at the public offering price, less the underwriting discounts and commissions ...What this means: InvestorsObserver gives Compass Therapeutics Inc. (CMPX) an overall rank of 34, which is below average. Compass Therapeutics Inc. is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 34 means that 66% of stocks appear more favorable to our system.

A high-level overview of Compass Therapeutics, Inc. (CMPX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.The Eterna Therapeutics 52-week low stock price is 0.84, which is 31.1% below the current share price. ... Compass Therapeutics (CMPX), United States, $0.215B ...SFIX Stock 12 Months Forecast. $3.68. (5.75% Upside) Based on 10 Wall Street analysts offering 12 month price targets for Stitch Fix in the last 3 months. The average price target is $3.68 with a high forecast of $5.00 and a low forecast of $2.50. The average price target represents a 5.75% change from the last price of $3.48. Compass Therapeutics (CMPX) Stock Forecast & Price Target $1.72 0.00 (0.00%) (As of 01:47 PM ET) Compare Today's Range $1.68 $1.72 50-Day Range $1.40 $2.13 52-Week …Instagram:https://instagram. best futures brokerjgasxtdv stockamazon stocks prediction Stock Price Forecast. The 5 analysts offering 12-month price forecasts for CompoSecure Inc have a median target of 13.00, with a high estimate of 15.00 and a low estimate of 7.00. The median ... Total Valuation. CMPX has a market cap or net worth of $224.33 million. The enterprise value is $55.37 million. Market Cap. 224.33M. Enterprise Value. 55.37M. cmgixchase refinance rate The projected low price target is $8.00 while the price target rests at a high of $11.00. In that case, then, we find that the current price level is -618.95% off the targeted high while a plunge would see the stock gain -422.88% from current levels. Compass Therapeutics Inc (CMPX) estimates and forecastsSee the latest Compass Therapeutics Inc Ordinary Shares stock price (NASDAQ:CMPX), related news, valuation, dividends and more to help you make your investing decisions. best no waiting period dental insurance Weather forecasts are essential tools for planning our daily activities, especially when it comes to the next 10 days. Understanding a weather 10 day forecast can help us make informed decisions about outdoor events, travel plans, or even w...Compound Price Live Data. The live Compound price today is $51.45 USD with a 24-hour trading volume of $77,211,369 USD. We update our COMP to USD price in real-time. Compound is up 1.11% in the last 24 hours. The current CoinMarketCap ranking is #107, with a live market cap of $412,787,173 USD. It has a circulating supply of 8,023,528 …